Actively Recruiting

Phase 1
Age: 21Years +
All Genders
NCT07049003

Deep Brain Stimulation of the Deep Cerebellar Nuclei for Refractory Tremor

Led by The Cleveland Clinic · Updated on 2025-07-03

12

Participants Needed

1

Research Sites

188 weeks

Total Duration

On this page

Sponsors

T

The Cleveland Clinic

Lead Sponsor

R

Raynor Cerebellum Project

Collaborating Sponsor

AI-Summary

What this Trial Is About

This objective of this study is to document the safety and feasibility of electrical stimulation of the deep cerebellar nuclei for refractory tremor using the Medtronic Percept RC Deep Brain Stimulation System. The population will consist of patients that have either failed a prior intervention (Vim DBS or HIFU thalamotomy) or determined to not be suitable candidates for Vim DBS or HIFU thalamotomy because they have a cerebellar outflow or MS-related tremor. Those patients with a previous intervention, must have a prior diagnosis of ET, cerebellar outflow tremor, or MS-related tremor. Subjects without a previous intervention must have a diagnosis of cerebellar outflow tremor or MS-related tremor.

CONDITIONS

Official Title

Deep Brain Stimulation of the Deep Cerebellar Nuclei for Refractory Tremor

Who Can Participate

Age: 21Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 21 years and older;
  • Ability to give informed consent;
  • Diagnosis of ET, cerebellar tremor, or MS-related tremor with a failed a prior intervention (VIM DBS or HIFU thalamotomy) or determined to not be suitable candidates for VIM DBS or HIFU thalamotomy because they have a cerebellar outflow or MS-related tremor.
  • Tremor history of at least three years;
  • Tremor that is refractory to medical management;
  • A score of ≥24 on the Mini Mental State Examination;
  • Inability to successfully perform ADLs without assistance or has lost interest in social, professional, or personal activities due to tremor
Not Eligible

You will not qualify if you...

  • Any other neurological condition that could reduce the safety of study participation including central nervous system vasculitis and intracranial malignancy
  • A condition that, in the opinion of the clinical investigator, would significantly increase the risk or interfere with study compliance, safety, or outcome;
  • A diagnosis of dementia;
  • Tremors due to other neurological conditions such as Parkinson's disease, dystonia, or other conditions not consistent with ET, cerebellar outflow tremor, or MS-related tremor.
  • Diagnosis of epilepsy;
  • Major active and untreated psychiatric illness that may interfere with study, such as psychotic disorders or severe personality disorders;
  • Untreated or inadequately treated depression defined by a score of 20 or greater on the Beck Depression Inventory-II at the time of enrollment;
  • At risk for suicide defined by a score greater or equal to 3 on the Columbia Suicide Severity Rating Scale (C-SSRS);
  • Pregnancy;
  • Unable to communicate with investigators or staff;
  • Surgical contraindications to DN DBS;
  • Contraindication to magnetic resonance (MRI) imaging, e.g., weight incompatible with scanner, implanted metallic devices or electrical devices (pacemaker, defibrillator, spinal cord stimulator, prior DBS) or intolerance to MRI contrast agent;
  • Enrolled in another device, biologic or pharmaceutical study within 30 days of consent in the current study, (i.e., patient cannot be enrolled if participation in another study was not completed at least 30 days prior to consent.);
  • Evidence of behavior(s) consistent with alcohol or substance abuse/dependence as defined by the criteria outlined in the DSM-V within the preceding six months;
  • Injection of botulinum toxins into the arm, neck or face within six months prior to baseline;

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Cleveland Clinic

Cleveland, Ohio, United States, 44195

Actively Recruiting

Loading map...

Research Team

J

Jeffrey Negrey, MA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here